CD28 and neoplasm: Increased expression and binding of CTLA-4 to CD28 contributes to the activation of intracellular mechanisms responsible for the immunosuppression of the cytotoxic tumour cell killing reaction by CD8+ cytotoxic cells (CTLs) and the immunotolerance of tumour neoantigens [329,344,345,346].